ArticleFrontiers in oncology2023

Tumor abnormal protein as a promising biomarker for screening solid malignancies and monitoring recurrence and metastasis.

Zhihui Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.